Clin2
NCT06723392Possibly a fitRecruiting

Treating bladder bacteria in pregnancy to prevent infections

Preterm BirthSmall for Gestational Age (SGA)StillbirthBacteriuria (Asymptomatic) in Pregnancy

Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.

This trial tests if a common antibiotic can safely treat bacteria in the urine of pregnant women who have no symptoms, to see if it prevents later infections. It focuses on women in low- and middle-income countries.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
1,134 people
Ages
18 years to 49 years
Study type
Interventional

Who can take part

  • You are between 12 and 20 weeks pregnant.
  • You are at least 18 years old (or the local legal adult age).
  • You have no symptoms of a urinary tract infection (like burning or urgency).
  • You have not taken any antibiotics in the last 14 days.
  • You do not have an allergy to nitrofurantoin (a common antibiotic).
  • You are not currently taking a magnesium-containing antacid.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07186465Recruiting· Phase 4
Preventing repeat bladder infections in postmenopausal women

This trial tests two approaches to prevent repeat bladder infections in postmenopausal women: a daily antibiotic pill or a vaginal tablet containing healthy bacteria and estrogen. The goal is to see which method works better over 6 months.

Bangkok, Phayatai Ratchathewi
NCT05652374Recruiting· Phase 4
Gag therapy for repeat bladder infections, compared to standard antibiotics

This trial tests a therapy (called GAG therapy) to prevent repeat urinary tract infections (UTIs) in adult women. It compares how similar the results are to a well-known antibiotic standard (nitrofurantoin) to see if it works reliably.

Nijmegen, Gelderland
NCT06907199Recruiting· Phase 1
Antibiotic vs. bladder treatment plus antibiotic for recurrent UTIs

This study compares taking a daily antibiotic (nitrofurantoin) alone versus having a procedure that cauterizes bladder areas (fulguration) plus the same daily antibiotic, to see which is better at preventing recurrent urinary tract infections in women.

Kansas City, Kansas
NCT07202949Recruiting· Phase 2
Extended antibiotics with methenamine for chronic urinary tract infection

This trial compares a longer, higher-dose antibiotic course combined with methenamine hippurate (a urinary antiseptic) against standard care (low-dose antibiotics or methenamine alone) for women with chronic urinary tract infections. It aims to see if the extended treatment is more effective at relieving persistent symptoms.

London
NCT06815549Not yet recruiting· Phase 3
Fluorothiazinone for recurrent bladder infections

This trial tests an investigational drug called Fluorothiazinone for women with recurring bacterial bladder infections. If you have frequent, painful urinary symptoms, this study might help assess a new treatment option.

NCT07871968Not yet recruiting· Phase 2
Antibiotic comparison for teenage urinary tract infections

This trial tests two antibiotics (pivmecillinam and nitrofurantoin) to see how well they treat uncomplicated urinary tract infections (UTIs) in girls aged 12 to under 18. If your daughter has a UTI, this study may help find a quick and effective treatment.

Dearborn Heights, Michigan

Hear when a new Preterm Birth trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.